TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 176 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83 | -42.8% | 9,307 | -1.6% | 0.00% | -50.0% |
| Q2 2023 | $145 | -32.2% | 9,454 | -0.6% | 0.01% | -33.3% |
| Q1 2023 | $214 | +6.5% | 9,508 | -0.3% | 0.01% | 0.0% |
| Q4 2022 | $201 | -99.9% | 9,541 | -16.9% | 0.01% | -18.2% |
| Q3 2022 | $283,000 | -19.4% | 11,477 | -20.8% | 0.01% | +10.0% |
| Q2 2022 | $351,000 | -5.9% | 14,485 | +0.2% | 0.01% | +11.1% |
| Q1 2022 | $373,000 | -27.6% | 14,461 | -12.9% | 0.01% | -18.2% |
| Q4 2021 | $515,000 | +28.4% | 16,601 | +0.4% | 0.01% | +22.2% |
| Q3 2021 | $401,000 | +59.8% | 16,527 | -4.1% | 0.01% | +80.0% |
| Q2 2021 | $251,000 | -38.3% | 17,237 | +5.7% | 0.01% | -37.5% |
| Q1 2021 | $407,000 | +116.5% | 16,307 | +137.0% | 0.01% | +100.0% |
| Q4 2020 | $188,000 | – | 6,881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |